BCL2 and neoplasm: Tumor cells acquire resistance to apoptosis by various mechanisms that interfere at different levels of apoptotic signaling, such as overexpression of anti-apoptotic genes (Bcl-2, IAPs) [55], [56] and alteration in the signaling pathways of tumor suppressors and oncogenes (p53, Akt) [57], [58].